Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Dropouts”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 433 records · Page 24Linked to original sources

[Therapy dropouts in closed groups].

Drop-outs in group psychotherapy are an everyday clinical problem. A premature quitting by one patient may have great consequences, especially in closed groups, not only for the drop-out but also for the remaining group members. Compared to the clinical relevance, empirical research on the conditions leading to a premature termination is quite meagre. Empirical basis of the study presented here are 58 groups with a total of 445 patients with a variety of symptoms and personality structures. All groups started with a 3 month inpatient period and were continued as a closed outpatient group for about 2 years. 110 patients (24.7%) left the group at least 3 months before the agreed end of the group. Empirical research on conditions leading to the premature drop-out is based on three perspectives: 1. patient-oriented: The values of certain patient variables e.g. symptoms, personality structure, socio-economic status etc. are considered as potential predictors. 2. institution-oriented: Here group characteristics are considered as the pool of potential predictors: e.g. group size, decisions made under time pressure, cotherapy etc. 3. group-oriented: The values of patient variables for one patient in relation to other group members (e.g. "isolated position") is considered here. From each perspective we were able to find potential relevant predictors.

Adaptation, Psychological↗

The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. II. The results of combined therapy. Side effects. The reasons for dropouts. Conclusion.

The efficacy and safety of nadolol (N), propranolol (PP), prazosin (PS) and a diuretic (D) were studied and compared with the aid of a total systems approach in a cooperative open study with participation of 10 centers of the USSR. As many as 419 men suffering from arterial hypertension (diastolic AP 95 mm Hg) were entered into the study. After randomization the patients received one of the 4 drugs. In case the monotherapy failed, combinations of 2-3 drugs were administered. The treatment lasted one year, with a monthly control being exercised. The patients' from the study accounted for 15% including the final points which constituted 1.9%. Of these, 6 patients suffered myocardial infarctions (one with a fatal outcome) and 2 presented with cerebral circulatory disorders. 3.8% of the patients were withdrawn from the study because of the side effects of the drugs. Out of 356 patients who completed the studies, 36.8% received one, 43% two, and 20.2% three drugs by the end of the year. The protocol of the study and the results of the monotherapy were provided in Communication I. Combined therapy with two or three drugs was effective whatever the combination and brought about a 12-16% decrease of diastolic AP. The negative chronotropic effect of N exceeded that of PP. The stable effect, t. e. the effect that lasted continuously over 6 months, was seen in less that half the patients treated for a year. Therefore, N is an effective, comparatively safe and long-acting beta-blocker. As for its efficacy, it does not yield to PP or PS and compares very favourably with D. The drug can successfully be used in long-term treatment of arterial hypertension.

Adult↗

The dropout patient.

Explore the source record for details and available documents.

Clinical Trials as Topic↗